Get the Stockscreener App
0.7001
5.05%
-0.0372
Aldeyra Therapeutics Inc Stock (ALDX) Forecast
The Aldeyra Therapeutics Inc (ALDX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.2696, representing a +81.35% increase from the current price of $0.7001. The highest analyst price target is $2.4455, and the lowest is $0.0937.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ALDX Price Target
Average 1.9271
(+175.27% Upside)
Is Aldeyra Therapeutics Inc (ALDX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 22.41 | Buy |
| STOCH(9,6) | 7.4224 | Buy |
| STOCHRSI(14) | 7.0485 | Buy |
| MACD(12,26) | -0.172 | Sell |
| ADX(14) | 38.35 | Sell |
| William %R | -93.67 | Buy |
| CCI(14) | -96.70 | Neutral |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.8696
Sell
|
0.8837
Sell
|
| MA20 |
1.0693
Sell
|
1.0247
Sell
|
| MA50 |
1.3208
Sell
|
1.2713
Sell
|
| MA100 |
1.5684
Sell
|
1.6052
Sell
|
| MA200 |
2.4618
Sell
|
2.3151
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ALDX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on ALDX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 22.41 indicates that ALDX is oversold. This indicates that ALDX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 7.4224 indicates that ALDX is oversold. This indicates that ALDX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 7.0485 indicates that ALDX is oversold. This suggests that ALDX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 38.35 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -96.7 indicates that ALDX is still oversold but not to an extreme extent.
Long-term ALDX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Aldeyra Therapeutics Inc financial reports and earnings history, Aldeyra Therapeutics Inc (ALDX) stock could reach $3.0692 by 2030, $7.0291 by 2040 and $30.14 by 2050. See the projected annual prices until 2050 of the Aldeyra Therapeutics Inc stock below:
- Aldeyra Therapeutics Inc (ALDX) is expected to reach an average price of $5.156 in 2035, with a high prediction of $5.4123 and a low estimate of $5.396. This indicates an $636.47% rise from the last recorded price of $0.7001.
- Aldeyra Therapeutics Inc (ALDX) stock is projected to chart a bullish course in 2040, with an average price target of $7.0109, representing an $901.42% surge from its current level. The forecast ranges from a conservative $7.1309 to a sky-high $7.0291.
- Our analysts predict Aldeyra Therapeutics Inc (ALDX) to jump 2,295% by 2045, soaring from $17.29 to an average price of $16.77, potentially reaching $17.89. While $17.29 is the low estimate, the potential upside is significant.
- Aldeyra Therapeutics Inc (ALDX) stock is expected to climb by 2050, reaching an average of $29.62, a $4,131% jump from its current level. However, a wide range of estimates exists, with high and low targets of $30.14 and $30.08, respectively, highlighting the market's uncertainty.
Aldeyra Therapeutics Inc Stock (ALDX) Year by Year Forecast
Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2026
The predicted value for Aldeyra Therapeutics Inc (ALDX) in 2026 is set at an average of $3.0118. Estimates vary from a peak of $5.93 to a trough of $0.0937, indicating an +330.20% surge from the present price of $0.7001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.4664 | $0.0937 | $2.4455 | -33.38% |
| December, 2026 | $2.9428 | $0.3809 | $0.8091 | +320.33% |
Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Aldeyra Therapeutics Inc (ALDX) is $1.9271, with a high forecast of $3.7803 and a low forecast of $0.074. This indicates an +175.27% increase from the last price of $0.7001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.7719 | $3.15 | $3.2619 | +438.77% |
| February, 2027 | $3.081 | $3.436 | $3.3065 | +340.09% |
| March, 2027 | $2.7175 | $2.9929 | $2.7656 | +288.15% |
| April, 2027 | $2.0166 | $2.202 | $1.9366 | +188.05% |
| May, 2027 | $3.903 | $2.1559 | $3.504 | +457.50% |
| June, 2027 | $3.4322 | $3.5122 | $3.7803 | +390.24% |
| July, 2027 | $2.7513 | $3.3006 | $3.3226 | +292.99% |
| August, 2027 | $1.0977 | $1.6077 | $2.3686 | +56.80% |
| September, 2027 | $0.7131 | $0.4204 | $1.7404 | +1.86% |
| October, 2027 | $0.434 | $0.074 | $1.4085 | -38.01% |
| November, 2027 | $0.8225 | $0.1933 | $0.5625 | +17.48% |
| December, 2027 | $0.5916 | $0.5143 | $0.4697 | -15.50% |
Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2028
In 2028, Aldeyra Therapeutics Inc (ALDX) is projected to reach an average price of $3.4368, with a high projection of $6.8561 and a low estimate of $0.0174. This indicates an +390.90% rise from the last price of $0.7001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.702 | $0.188 | $0.737 | +0.27% |
| February, 2028 | $1.2328 | $0.0174 | $1.4228 | +76.09% |
| March, 2028 | $0.4537 | $0.2637 | $1.4855 | -35.20% |
| April, 2028 | $1.5645 | $0.1364 | $1.5745 | +123.47% |
| May, 2028 | $2.1181 | $1.21 | $2.648 | +202.54% |
| June, 2028 | $5.099 | $1.9009 | $5.544 | +628.32% |
| July, 2028 | $4.6225 | $3.6644 | $5.5371 | +560.27% |
| August, 2028 | $5.9334 | $3.9253 | $6.8034 | +747.51% |
| September, 2028 | $2.6643 | $0.3788 | $6.8561 | +280.55% |
| October, 2028 | $3.0978 | $2.5774 | $3.4478 | +342.48% |
| November, 2028 | $2.6187 | $2.1983 | $3.2205 | +274.05% |
| December, 2028 | $1.3895 | $1.3695 | $2.8414 | +98.48% |
Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2029
The 2029 price forecast for Aldeyra Therapeutics Inc Stock (ALDX) is $1.4848 on average, with a high prediction of $2.9669 and a low estimate of $0.00273. This represents an +112.08% increase from the previous price of $0.7001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.1669 | $0.5377 | $2.9669 | +352.35% |
| February, 2029 | $1.696 | $2.316 | $2.8442 | +142.25% |
| March, 2029 | $1.2952 | $1.6152 | $1.6534 | +85.00% |
| April, 2029 | $1.1316 | $1.047 | $1.1725 | +61.63% |
| May, 2029 | $1.0707 | $1.1734 | $1.1162 | +52.94% |
| June, 2029 | $0.5399 | $0.6899 | $0.878 | -22.89% |
| July, 2029 | $0.7763 | $0.5171 | $1.044 | +10.88% |
| August, 2029 | $0.0254 | $0.0941 | $0.9541 | -96.37% |
| September, 2029 | $0.0854 | $0.00273 | $0.5154 | -87.80% |
| October, 2029 | $0.271 | $0.0919 | $0.4436 | -61.29% |
| November, 2029 | $0.1598 | $0.0698 | $0.7298 | -77.17% |
| December, 2029 | $1.5234 | $0.1326 | $1.8993 | +117.60% |
Aldeyra Therapeutics Inc Stock (ALDX) Price Forecast for 2030
Aldeyra Therapeutics Inc Stock (ALDX) is expected to reach an average price of $2.2241 in 2030, with a high forecast of $4.403 and a low forecast of $0.0453. This signifies an +217.69% surge from the last price of $0.7001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.5743 | $1.4961 | $3.0692 | +267.70% |
| February, 2030 | $1.9751 | $1.7551 | $2.707 | +182.12% |
| March, 2030 | $1.986 | $1.6878 | $2.8728 | +183.67% |
| April, 2030 | $1.7396 | $0.8841 | $2.5114 | +148.47% |
| May, 2030 | $1.8704 | $1.5523 | $2.3577 | +167.16% |
| June, 2030 | $1.8613 | $1.6813 | $2.5558 | +165.86% |
| July, 2030 | $3.8248 | $1.794 | $4.0548 | +446.33% |
| August, 2030 | $3.8057 | $1.9376 | $4.403 | +443.59% |
| September, 2030 | $0.4707 | $0.7207 | $4.0578 | -32.76% |
| October, 2030 | $0.3899 | $0.0453 | $0.2974 | -44.31% |
| November, 2030 | $0.181 | $0.3744 | $0.2342 | -74.15% |
| December, 2030 | $1.9346 | $0.1537 | $1.9696 | +176.33% |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):